Current Opinion in Biotechnology

Papers
(The H4-Index of Current Opinion in Biotechnology is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Editorial Board169
Editorial Board149
Corrigendum to “Methylotrophs: from C1 compounds to food” [Curr Opin Biotechnol 75 (2022) 102685]134
Anaerobic microbial methanol utilization as a one-carbon feedstock115
The osteo-angiogenic signaling crosstalk for bone regeneration: harmony out of complexity111
Bacterial degradation of emerging aromatic pollutants and integrated strategies for sustainable healthy agro-ecosystem105
Recent progress in the synthesis of advanced biofuel and bioproducts100
Tumor lipid metabolism: a mechanistic link between diet and cancer progression97
Creating value from purple phototrophic bacteria via single-cell protein production95
The journey of a lifetime — development of Pfizer’s COVID-19 vaccine91
Spatial enzyme assembly for microbial pharmaceutical synthesis89
Cytochrome P450-mediated structural diversification of diketopiperazine alkaloids83
Advances in synthetic microbial consortia for improved production of biochemicals and biofuels80
Synthetic biology advances towards a bio-based society in the era of artificial intelligence79
How much could improving photosynthesis increase crop yields? A call for systems-level perspectives to guide engineering strategies72
Cell-free technologies for biopharmaceutical research and production72
Systems biology-based analysis of cell-free systems69
A molecular assessment of the practical potential of DNA-based computation69
Editorial Board68
Whole-plant phenotypic engineering: moving beyond ratios for multi-objective optimization of nutrient use efficiency67
Innovations and trends in antibody repertoire analysis65
Recent advances, opportunities and challenges in cybergenetic identification and control of biomolecular networks65
Deep learning in regulatory genomics: from identification to design65
Editorial Board61
Engineered T cells and macrophages: two arms to seize solid tumors60
Expanding the catalytic repertoire of C–C bond–forming pyridoxal 5′-phosphate-dependent enzymes for noncanonical amino acid formation60
Coupling chemistry and biology for the synthesis of advanced bioproducts59
Single-cell analysis opens a goldmine for plant functional studies58
Lighting the way: recent developments and applications in molecular optogenetics58
Metabolic engineering of microorganisms for the production of fatty acid-derived biofuels57
Molecular methods for high-throughput, multiplexed, and automated genome editing in prokaryotes and eukaryotes57
Strategies and challenges for synthetic apomixis57
Emerging technologies for genetic control systems in cellular therapies57
Engineered living bioassemblies for biomedical and functional material applications57
Microfluidics meets cell-free systems: from molecular engineering to synthetic cells56
Multifaceted metabolic role of infections in the tumor microenvironment55
Engineering of the genetic code54
Dietary microalgae on poultry meat and eggs: explained versus unexplained effects54
Computational tools and resources for designing new pathways to small molecules53
2-hydroxyglutarate rides the cancer-immunity cycle52
Mass spectrometry imaging methods for visualizing tumor heterogeneity51
Biocatalytic cascade transformations for the synthesis of C-nucleosides and N-nucleoside analogs51
Photoprotective-based strategies to enhance crop yield under fluctuating light conditions50
Emerging trends in production of plant natural products and new-to-nature biopharmaceuticals in yeast50
Deciphering the guanidine code: from core metabolism to biosynthesis of its derivatives50
Using genome and transcriptome analysis to elucidate biosynthetic pathways49
Machine learning to navigate fitness landscapes for protein engineering49
Perspectives for self-driving labs in synthetic biology48
Strategies for engineering domesticated and undomesticated human microbes48
Tissue engineering in the agri-food industry: current status, socio-economic overview and regulatory compliance48
0.075898885726929